These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The hematopoietic microenvironment of the fetal liver and transient abnormal myelopoiesis associated with Down syndrome: A review. Miyauchi J. Crit Rev Oncol Hematol; 2024 Jul; 199():104382. PubMed ID: 38723838 [Abstract] [Full Text] [Related]
3. Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update. Bhatnagar N, Nizery L, Tunstall O, Vyas P, Roberts I. Curr Hematol Malig Rep; 2016 Oct; 11(5):333-41. PubMed ID: 27510823 [Abstract] [Full Text] [Related]
4. A Case of Novel GATA-1 Mutation-positive Transient Abnormal Myelopoiesis With Life-threatening Complications in a Neonate With Down Syndrome. Sah RR, Ray S, Bhatia P, Dhir SK, Totadri S, Kumar N, Kumar P. J Pediatr Hematol Oncol; 2021 Mar 01; 43(2):e292-e295. PubMed ID: 31876781 [Abstract] [Full Text] [Related]
5. The impact of trisomy 21 on early human hematopoiesis. Roy A, Cowan G, Vyas P, Roberts I. Cell Cycle; 2013 Feb 15; 12(4):533-4. PubMed ID: 23343767 [No Abstract] [Full Text] [Related]
6. Thrombocytosis in a newborn with Down syndrome and transient abnormal myelopoiesis. Fujihara I, Yanagisawa R, Fukushima Y, Komori K, Ogiso Y, Sakashita K. Br J Haematol; 2016 Feb 15; 172(3):314. PubMed ID: 26457464 [No Abstract] [Full Text] [Related]
7. Basophilic differentiation in transient abnormal myelopoiesis. Bain BJ. Am J Hematol; 2016 Aug 15; 91(8):847. PubMed ID: 27192361 [No Abstract] [Full Text] [Related]
10. Predictive factors for the development of leukemia in patients with transient abnormal myelopoiesis and Down syndrome. Yamato G, Deguchi T, Terui K, Toki T, Watanabe T, Imaizumi T, Hama A, Iwamoto S, Hasegawa D, Ueda T, Yokosuka T, Tanaka S, Yanagisawa R, Koh K, Saito AM, Horibe K, Hayashi Y, Adachi S, Mizutani S, Taga T, Ito E, Watanabe K, Muramatsu H. Leukemia; 2021 May 15; 35(5):1480-1484. PubMed ID: 33654203 [No Abstract] [Full Text] [Related]
17. [Myeloid proliferations related to Down syndrome]. Hasegawa D. Rinsho Ketsueki; 2019 Apr 15; 60(9):1299-1307. PubMed ID: 31597856 [Abstract] [Full Text] [Related]
18. Perinatal visceral fibrosis accompanying the megakaryoblastic leukemoid reaction of Down syndrome. Becroft DM, Zwi LJ. Pediatr Pathol; 1990 Apr 15; 10(3):397-406. PubMed ID: 2140891 [Abstract] [Full Text] [Related]
19. Neonatal vesiculopustular eruption in Down syndrome and transient myeloproliferative disorder: A case report and review of the literature. Brazzelli V, Segal A, Bernacca C, Tchich A, Bolcato V, Croci G, Mina T, Zecca M, Zanette S, Stronati M. Pediatr Dermatol; 2019 Sep 15; 36(5):702-706. PubMed ID: 31355466 [Abstract] [Full Text] [Related]
20. Microvesicular Steatosis with Transient Abnormal Myelopoiesis-Associated Hepatic Fibrosis. Kakiuchi T, Minematsu N. Indian J Pediatr; 2022 Aug 15; 89(8):814-815. PubMed ID: 35366199 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]